Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 3
2005 4
2006 1
2007 3
2008 2
2009 4
2010 3
2011 6
2012 6
2013 2
2014 4
2015 4
2016 4
2017 2
2018 2
2019 1
2020 1
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling.
Sankar AP, Cho HM, Shin SU, Sneh T, Ramakrishnan S, Elledge C, Zhang Y, Das R, Gil-Henn H, Rosenblatt JD. Sankar AP, et al. Among authors: rosenblatt jd. Cancer Res Commun. 2024 Mar 11;4(3):738-756. doi: 10.1158/2767-9764.CRC-23-0278. Cancer Res Commun. 2024. PMID: 38315147 Free PMC article.
Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
Shin SU, Cho HM, Das R, Gil-Henn H, Ramakrishnan S, Al Bayati A, Carroll SF, Zhang Y, Sankar AP, Elledge C, Pimentel A, Blonska M, Rosenblatt JD. Shin SU, et al. Among authors: rosenblatt jd. Cells. 2021 Oct 27;10(11):2904. doi: 10.3390/cells10112904. Cells. 2021. PMID: 34831127 Free PMC article.
Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation.
Alderuccio JP, Zhao W, Desai A, Ramdial J, Gallastegui N, Kimble E, de la Fuente MI, Husnain M, Rosenblatt JD, Alencar AJ, Schatz JH, Moskowitz CH, Chapman JR, Vega F, Reis IM, Lossos IS. Alderuccio JP, et al. Among authors: rosenblatt jd. Am J Hematol. 2019 May;94(5):585-596. doi: 10.1002/ajh.25446. Epub 2019 Mar 10. Am J Hematol. 2019. PMID: 30784098 Free article. Clinical Trial.
Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution.
Alderuccio JP, Zhao W, Desai A, Gallastegui N, Ramdial J, Kimble E, de la Fuente MI, Rosenblatt JD, Chapman JR, Vega F, Reis IM, Lossos IS. Alderuccio JP, et al. Among authors: rosenblatt jd. J Clin Oncol. 2018 Oct 12:JCO1800138. doi: 10.1200/JCO.18.00138. Online ahead of print. J Clin Oncol. 2018. PMID: 30312133
Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.
Pro B, Advani R, Brice P, Bartlett NL, Rosenblatt JD, Illidge T, Matous J, Ramchandren R, Fanale M, Connors JM, Fenton K, Huebner D, Pinelli JM, Kennedy DA, Shustov A. Pro B, et al. Among authors: rosenblatt jd. Blood. 2017 Dec 21;130(25):2709-2717. doi: 10.1182/blood-2017-05-780049. Epub 2017 Oct 3. Blood. 2017. PMID: 28974506 Free PMC article. Clinical Trial.
55 results